Genetix Pharmaceuticals, Inc. – Trademark Portfolio
Entity Type: 03
Genetix Pharmaceuticals, Inc. holds 19 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 18 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include LENTIGLOBIN and BLUEBIRD BIO. The owner is based in Cambridge, MA.
840 Memorial Drive
Cambridge, MA 02139
Showing of trademarks Trademarks
Trademark Classifications
Genetix Pharmaceuticals, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Genetix Pharmaceuticals, Inc. have?
Genetix Pharmaceuticals, Inc. has 19 U.S. trademarks filed with the USPTO. Of these, 2 registered, 13 abandoned, 4 cancelled.
What trademark classes does Genetix Pharmaceuticals, Inc. file in?
Genetix Pharmaceuticals, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Genetix Pharmaceuticals, Inc.'s most well-known trademarks?
Genetix Pharmaceuticals, Inc.'s registered trademark portfolio includes well-known marks such as LENTIGLOBIN and BLUEBIRD BIO. These are among 2 currently registered trademarks in the portfolio.
What is Genetix Pharmaceuticals, Inc.'s trademark registration success rate?
Genetix Pharmaceuticals, Inc. has a 11% trademark registration rate, with 2 out of 19 resolved applications resulting in successful registration. Currently, 0 applications are pending review.